Wilson C, Senior B W, Tiwana H, Caparros-Wanderley W, Ebringer A
Division of Life Sciences, King's College, London, UK.
Rheumatol Int. 1998;17(5):203-5. doi: 10.1007/s002960050035.
Urinary isolates of Proteus mirabilis, obtained from 49 RA patients and 44 healthy controls, were tested for susceptibility to antibiotics by the disc diffusion method. In addition, P. mirabilis isolates were also tested for proticine production and sensitivity (p/s) typing by the inhibition of growth of each test isolate against 13 reference strains of P. mirabilis. The P. mirabilis isolates from both RA patients and healthy controls were highly susceptible to norfloxacin, ciprofloxacin and trimethoprim, but less to minocycline. The urine of RA patients contained fewer different types of P. mirabilis strains than those isolated from healthy controls. All of the strains found in the RA patients were proticine producers (P < 0.001), mostly of proticine 3 (P < 0.005). The presence of such strains provides evidence of a sub-clinical upper urinary tract infection with P. mirabilis in some RA patients. Therapeutic intervention in RA with relevant antibiotics requires evaluation.
从49例类风湿关节炎(RA)患者和44例健康对照者中分离出奇异变形杆菌的尿液菌株,采用纸片扩散法检测其对抗生素的敏感性。此外,通过检测各测试菌株对13株奇异变形杆菌参考菌株的生长抑制情况,对奇异变形杆菌分离株进行产质子菌素及敏感型(p/s)分型检测。RA患者和健康对照者的奇异变形杆菌分离株对诺氟沙星、环丙沙星和甲氧苄啶高度敏感,但对米诺环素敏感性较低。RA患者尿液中分离出的奇异变形杆菌菌株类型比健康对照者少。RA患者中发现的所有菌株均为产质子菌素菌株(P<0.001),大多数为质子菌素3型(P<0.005)。这些菌株的存在为部分RA患者存在奇异变形杆菌亚临床上尿路感染提供了证据。对RA患者使用相关抗生素进行治疗干预需要进行评估。